Bowel perforation associated with intraperitoneal chromic phosphate instillation.
Intraperitoneal chromic phosphate is widely used as adjuvant therapy in the treatment of early-stage ovarian epithelial carcinoma. Delayed bowel injury is an infrequently observed complication of chromic phosphate administration. This report presents a case of colon perforation which occurred 4 months after treatment with intraperitoneal chromic phosphate for stage IB ovarian papillary serous cystadenocarcinoma.
Proctor
J
J
Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, DC 20307.
Doering
D
D
Barnhill
D
D
Park
R
R
D002857:Chromium / Q000008:administration & dosage / Q000009:adverse effects*; D017608:Chromium Compounds; D003108:Colonic Diseases / Q000209:etiology*; D003536:Cystadenocarcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007416:Intestinal Perforation / Q000209:etiology*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010710:Phosphates / Q000008:administration & dosage / Q000009:adverse effects*
D017608:Chromium Compounds; D010710:Phosphates; D002857:Chromium; C509369:chromic phosphate